Composite outcomes in clinical trials
OBJECTIVESUsing composite endpoints permits to decrease sample size needs, to better assess the net effect of an intervention and to minimize bias in presence of competing risks. This course intends to give you knowledge and expertise on the risk of misinterpretation related to the magnitude of treatment effect.
LEARNING OUTCOMESAt the end of this course, you will be able to understand and iscuss the main advantages and limitations of using combined outcomes in clinical trials and how to make a rationale interpretation of this kind of variables.
|
|
AUTHORS
Josep Maria Castel Universitat Autònoma de Barcelona |
Dr. Antònia Agustà Universitat Autònoma de Barcelona |
Dr. Xavier Vidal Universitat Autònoma de Barcelona |
Dr. Montse Bosch Doctor of Medecine |